Gaurov Dayal

Gaurov Dayal is a Scientific Advisor at Novocardia. Gaurov was previously the President and Chief Operating Officer at Everside Health from January 2021 to June 2022. Prior to that, they were the President, New Markets and Chief Growth Officer at ChenMed from January 2017 to December 2021. Gaurov also served as the SVP, Health System Solutions and Strategy at Lumeris from January 2015 to December 2017. Gaurov Dayal has also been the President, Health Care Delivery, Financing and Integration at SSM Health Care from January 2012 to December 2015. Gaurov started their career as the President, Adventist Medical Group and Chief Medical Officer at Adventist HealthCare from January 2005 to December 2012.

Gaurov Dayal received a BA in Natural Sciences from The Johns Hopkins University. Gaurov then attended Northwestern University - The Feinberg School of Medicine, where they earned their MD. Gaurov completed their residency training at Washington University School of Medicine in St. Louis.